Table 4. Estimated sensitivity of the 1997 ACR classification criteria for SLE and the 2019 EULAR/ACR classification criteria for SLE in the incident Southeast Norway SLE cohort during 2000–2017, at time of diagnosis, 2 years after diagnosis and at last visit in study period.
Classification criteria | Proportion of cases meeting criteria, % (95% CI) n1/n2, | |||
At time of diagnosis | 2 years after diagnosis* | At last visit in study period | ||
Adult-onset SLE | ||||
Total | 2019 EULAR/ACR | 91.6 (89.5–93.6)642/701 | 92.7 (90.6–94.7)568/613 | 94.0 (92.3–95.8)659/701 |
1997 ACR | 77.3 (74.2–80.4)542/701 | 82.5 (79.5–85.5)506/613 | 84.3 (81.6–87.0)591/701 | |
P<0.001 | P<0.001 | P<0.001 | ||
Female | 2019 EULAR/ACR | 92.5 (90.4–94.7)546/590 | 93.6 (91.4–95.7)480/513 | 94.6 (92.7–96.4)558/590 |
1997 ACR | 79.0 (75.7–82.3)466/590 | 83.6 (80.4–86.8)429/513 | 85.6 (82.8–88.4)505/590 | |
P<0.001 | P<0.001 | P<0.001 | ||
Male | 2019 EULAR/ACR | 86.5 (80.1–92.8)96/111 | 88.0 (81.6–94.4)88/100 | 91.0 (85.7–96.3)101/111 |
1997 ACR | 68.5 (59.8–77.1)76/111 | 77.0 (68.6–85.2)77/100 | 77.5 (69.7–85.2)86/111 | |
P<0.001 | P<0.05 | P<0.05 | ||
Juvenile-onset SLE‡ | ||||
Total | 2019 EULAR/ACR | 97.2 (91.9–102.6)35/36 | 100 (100–100)25/25 | 97.2 (91.9–102.6)35/36 |
1997 ACR | 88.9 (78.6–99.2)32/36 | 92.0 (81.4–102.6)23/25 | 91.7 (82.6–100.7)33/36 | |
Female | 2019 EULAR/ACR | 96.6 (89.9–103.1)28/29 | 100 (100–100)21/21 | 96.6 (89.9–103.2)28/29 |
1997 ACR | 89.7 (78.5–100.7)26/29 | 90.5 (77.9–102.6)19/21 | 89.7 (78.6–100.7)26/29 | |
Male | 2019 EULAR/ACR | 100†7/7 | 100†4/4 | 100†7/7 |
1997 ACR | 85.7†6/7 | 100†4/4 | 100†7/7 |
The 1997 ACR criteria, the 1997 American College of RheumatologyACR classification criteria for Systemic Lupus ErythematousSLE; the 2019 EULAR/ACR criteria, the 2019 European Alliance of Associations for Rheumatology/American College of RheumatologyEULAR/ACR classification criteria for Systemic Lupus Erythematous; n, number of cases fulfilling the criteria; n total number of cases at visit,SLE.
n1, number of cases fulfilling the criteria; n2,, total number of cases at visit
eEstimated sensitivity two2 years after diagnosis includes only the 64238 incident cases during 2000–2015 to allow for two2-year follow upfollow-up for all cases.
lLess than 10 cases cases, and to scarce for statistical analysis.
2019 EULAR/ACR criteria fulfilment vs 1997 ACR criteria fulfilment did not differ significantly.
EULAR/ACREuropean Alliance of Associations for Rheumatology/American College of RheumatologySLEsystemic lupus erythematosus